Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF‐κB system in high‐fat‐fed rabbits
- 12 August 2013
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 55 (4), 388-398
- https://doi.org/10.1111/jpi.12085
Abstract
Vascular endothelial dysfunction (VED) and inflammation contribute to the initiation and progression of atherosclerosis. Melatonin (MLT) normalizes lipid profile, improves endothelial function, and possesses anti‐inflammatory properties. However, the precise mechanisms are still unclear. This study investigated whether MLT could ameliorate VED, inflammation, and atherosclerosis by suppressing the Toll‐like receptor 4 (TLR4)/nuclear factor kappa B (NF‐κB) system in high‐fat‐fed rabbits. Rabbits were randomly divided into three groups that received a standard diet (control group), high‐cholesterol diet (atherosclerosis group), or high‐cholesterol diet plus 10 mg/kg/day MLT (MLT group) for 12 wk. After treatment, high‐fat diet significantly increased serum lipid and inflammatory markers in rabbits in atherosclerosis group compared with that in control group. In addition, high‐fat diet also induced VED and typical atherosclerotic plaque formation and increased intima/media thickness ratio, which were significantly improved by MLT therapy as demonstrated in MLT group. Histological and immunoblot analysis further showed that high‐fat diet enhanced the expressions of TLR4, myeloid differentiation primary response protein (MyD88), and NF‐κB p65, but decreased inhibitor of NF‐κB (IκB) expression. By contrast, MLT therapy decreased the expressions of TLR4, MyD88, and NF‐κB p65 and increased IκB expression. This study has demonstrated that MLT ameliorates lipid metabolism, VED, and inflammation and inhibits the progression of atherosclerosis in high‐fat‐fed rabbits. Moreover, our study indicates for the first time that suppression of the TLR4/NF‐κB system in local vasculature with atherosclerotic damage is important for the protective effects of MLT.Keywords
Funding Information
- Anhui Provincial Natural Science Foundation (11040606Q20, 11040606M157)
- Key University Natural Science Foundation of Anhui Province (KJ2012A147)
- Specialized Research Fund for the Doctoral Program of Higher Education of China (20123420120005)
- Cultivating Program of National Natural Science Foundation (2009kj18, 2010xkj071)
This publication has 69 references indexed in Scilit:
- Immune-Pineal Axis: Nuclear Factor κB (NF-kB) Mediates the Shift in the Melatonin Source from Pinealocytes to Immune Competent CellsInternational Journal of Molecular Sciences, 2013
- Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontiumLipids in Health and Disease, 2013
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCsJCI Insight, 2012
- All-trans-Retinoic Acid Ameliorated High Fat Diet-Induced Atherosclerosis in Rabbits by Inhibiting Platelet Activation and InflammationJournal of Biomedicine and Biotechnology, 2012
- Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4Online Journal of Public Health Informatics, 2011
- Toll-like Receptor 4 Signaling Confers Cardiac Protection against Ischemic Injury via Inducible Nitric Oxide Synthase- and Soluble Guanylate Cyclase-dependent MechanismsAnesthesiology, 2011
- Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathyLife Sciences, 2010
- Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarctionClinical Science, 2008
- Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal modelInternational Journal of Experimental Pathology, 2006
- Effect of melatonin on vascular reactivity in pancreatectomized ratsLife Sciences, 2004